Key Takeaways
- Execution quarter, not a strategy quarter: Management framed Q1 as pure execution, with green shoots visible across businesses, but consolidated revenue declined sequentially and EBITDA losses widened on the lumpy absence of a prior-quarter DM fee.
- Noida finally converts: Offers of possession issued to all 340 residents in June 2026, with ~75% of dues collected by the call date; revenue recognition and inventory write-offs land in Q2, not Q1.
- AGEasy absorbs the brand bet: Revenue dipped QoQ on seasonality, but ROAS improved to 2.0, gross margin held at 45%, and July ARR picked up to ~₹10 crores after the Anupam Kher campaign.
- Pipeline math is material: Bangalore and Dehradun opportunities together represent ~₹1,800 crores of sales value toward the 0.15 crore sq ft ambition, with diligence in final stages.
- What to watch next quarter: Whether Noida Phase II approval moves forward, whether the promised EBITDA loss ratio reduction actually shows up, and whether AGEasy's festive-season surge confirms the July ARR signal.
Noida: The Quarter's Anchor Event
- Possession milestone reached: Offers of possession went to all 340 residents in June 2026 after a long wait, making Antara Noida the first operational community in NCR.
- Collections are running ahead of recognition: Approximately 75% of total dues were collected by the call date, with most arriving in July and August after ₹30-odd crores came in during June alone.
- Recognition waits for Q2: No revenue was recognized in Q1 because recognition is tied to possession and registration, not collection; possessions are scheduled for Q2, when all revenue recognition and inventory write-offs will occur.
- Residents are imminent: 200 to 300 people are expected to move in within 30 to 45 days of the call, and the team is ready to welcome them within weeks.
- Phase II is where the profit sits: Current Phase II rates run ₹16,000 to ₹18,000+ per sq ft versus Phase I's ₹7,000 to ₹10,000 average, so management's focus now shifts to getting Phase II approval.
Mehta: "After that, the focus will now shift to saying that can we go ahead and get the approval for Phase II, which is where we realize most of our profits."
AGEasy: Brand Spend, Seasonality, and the Path to Breakeven
- QoQ decline was seasonal, not structural: Revenue fell from Q4 because March quarters always spike to cover annual targets; Q4 last year also had a transition-driven aberration.
- Marketing efficiency improved: Overall ROAS exit rose to 2.0 from 1.8 in Q4, with marketplaces at 3.8 and D2C exit at 2.6; management says this creates a strong base for Q2 through Q4 growth.
- Gross margin held despite logistics pain: Margin stayed at 45% versus 46% in Q4 even as geopolitical issues pushed up COGS and forced airlifting of some China-sourced products.
- Brand spend is showing payback: The Anupam Kher campaign hit the P&L in Q1, but July ARR picked up to about ₹10 crores, conversion rates improved from 2 to 3.5, and ROAS went up.
- EBITDA stayed flat despite the spend: AACS EBITDA losses were ₹19 crores in Q1 versus ₹18.5 crores in Q4, with revenue up QoQ, meaning the brand investment was absorbed without widening losses.
- Repeat dynamics are a known constraint: Repeat rate is 10 to 12%, and same-product repeats are structurally low because products like BP monitors do not lend themselves to frequent repurchase; cross-sell is the real opportunity and an engine is being built for it.
- Profitability commitment stands: Management expects AGEasy to be in the profitability zone by January or the last quarter of FY27, with marketplaces CM2 at minus 17% in July and improving toward breakeven by Q4.
Mehta: "As I said, AGEasy perhaps by January or last quarter of this year will be in that zone."
Care Homes: Occupancy Ramping, Expansion Decision Still on Hold
- Occupancy is trending the right way: OBDs rose 23% QoQ, with 5 of 8 Care Homes trending per the operating model and specific gains at Bannerghatta, Gurugram, Whitefield, and OMR Chennai.
- DLF Phase II relaunched: The Gurgaon center was completed and relaunched in July 2026, bringing all 8 Care Home centers to operational status.
- Dehradun is stable and profitable: Revenue dipped marginally by ₹7 lakh on club membership cyclicality, but operations profit rose 2.3x YoY on cost optimization; the community is fully occupied, so future growth will be linear.
- Expansion decision waits for the inflection point: Management set October to November as the moment to evaluate expansion, and is sticking to that timeline with no changes.
- Unit economics need patience: Beds built in the last 12 months must wait out the 8 to 10 quarters it takes for beds to be profitable at the unit level.
- Blended ARPOB target: Once occupancy rises, blended ARPOB should land near ₹7,500.
Pipeline & Growth Capital
- Bangalore is in final diligence: Approximately 300-odd units in north Bangalore, Devanahalli, 25 minutes from the airport and overlooking Nandi Hills, with potential realization of about ₹900 crores in sales value.
- Dehradun expansion is being pursued aggressively: A small land parcel, possibly under 150 units, could carry sales value of ₹850 to ₹900 crores at current prices, supported by a long waiting list and no inventory to sell.
- Combined commitment math: Bangalore and Dehradun together represent about ₹1,800 crores of value toward the 0.15 crore sq ft ambition, with disclosures promised once definitive documents are executed.
- Other geographies in dialogue: Chennai, Chandigarh, and Lucknow are all in conversation.
- Setbacks were absorbed: Chandigarh had to be unwound because height clearances were not given after Operation Sindoor, and the Bangalore project's developer ran into financial issues, causing a pause.
- DLF competition is not hurting: DLF announced senior living entry about six months ago but has delayed launch consistently; management says Gurgaon sales velocity is exactly on plan for the year.
Financials & Capital
- Sequential revenue decline explained: Consolidated revenue marginally declined QoQ primarily because DM income is lumpy by nature.
- EBITDA loss widened on an exceptional: The QoQ profitability decline reflects the impact of an exceptional DM fee received in Q4 FY26, not a deterioration in underlying operations.
- Employee expense aberration is an accounting artifact: Each year the company provides for variable pay, provisions get trued up when paid in May for Q4, then Q1 starts providing again; some provisions were written back this quarter.
- Labour codes added cost: Labour code changes pushed up manpower cost for the quarter.
- Inventory is under pressure: Inventory days are stressed because of logistics costs and ship availability issues bringing material from China given the geopolitical situation.
- Fund raise deferred, not cancelled: The second fund raise was pushed out from June due to better performance, available credit lines for working capital and inventory, and Noida possession collections; total capital requirement is unchanged.
- Capital need is shrinking: Total capital required for the next two years is now about $20 million or under, down from a ~$25 million peak.
- ₹40 crores received: The second tranche of the preferential issue came in during July.
Mehta: "The geopolitical issue caused the logistics cost and delivery from China impacted. And we had to airlift some products, which caused a margin depression. But all these in the current world are things I think any business should just embrace and keep moving on."
Competitive Position & Moats
- Patents are the product moat: AGEasy has 4 patents granted and 3 more filed for senior-specific innovative products; management sees this as the biggest differentiator.
- Brand is the only other moat: Management is explicit that on AGEasy, only differentiated, innovated products and brand matter; nothing else is a moat.
- Hospital chains entering Care Homes face a margin question: Management's pushback is that a hospital entering Care Homes is diluting its margins, a question investors should ask.
- Wellness Clinic is an embedded differentiator, not a standalone bet: Integrated wellness (AIWC) will be embedded in all residences as a differentiator and tried in Care Homes as OPDs to attract footfalls; standalone clinic revenue contribution is difficult to predict.
- Partnerships are stacking up: Work continues with Star Union Dai-ichi Life on senior financial products, IIT Delhi on mobility products, Wellbeing Nutrition on nutraceuticals, and Swassa on lung health self-diagnosis.
Mehta: "On AGEasy, there are only 2 moats, which is (a) differentiated, innovated products, which are senior specific and (b) brand. Nothing else is a moat."
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Noida Phase I revenue recognition | Possessions scheduled, triggering revenue recognition and inventory write-offs | Q2 FY27 |
| Noida Phase II approval | Focus shifts to getting approval where most profits are realized | No date; next focus after Phase I possessions |
| Bangalore project | ~300 units, ~₹900 crores sales value, final diligence stage | Definitive documents pending |
| Dehradun expansion | Under 150 units, ₹850–900 crores sales value | Definitive documents pending |
| AGEasy profitability | Breakeven zone | January or last quarter FY27 |
| AGEasy CM2 breakeven | Marketplaces CM2 at minus 17% in July, improving | Q4 FY27 |
| AGEasy FY27 revenue | Double from ₹77 crores to ₹150-odd crores | FY27 |
| Care Home expansion decision | Evaluate after October–November inflection point | October–November FY27 |
| EBITDA loss ratio reduction | Management promises reduction in the 63% EBITDA loss ratio will be visible | Next quarter |
| Capital requirement | ~$20 million or under for next 2 years | FY27–FY28 |
Key Metrics
| Metric | Q1 FY27 |
|---|---|
| Consolidated revenue | ₹68.6 cr, +66% YoY; declined marginally QoQ due to lumpy DM income |
| Consolidated EBITDA loss | ₹25 cr, vs ₹23.2 cr in Q1 FY26 and ₹6.8 cr in Q4 FY26 |
| Treasury assets (Max India standalone) | ₹21 cr as of June 30, 2026 |
| Consolidated net worth | ₹372 cr as of June 30, 2026 |
| Senior living segment revenue | ~₹38 cr, comprising ~₹8 cr treasury income and ~₹30 cr core operations |
| Senior living core ops: DM fee | ~₹7 cr |
| Senior living core ops: finance lease income | ~₹15 cr, exceptional, from 4 re-leased units in Dehradun |
| Dehradun operating revenue | ₹6.2 cr, 1.1x YoY; marginally down ₹7 lakh QoQ |
| Dehradun operations profit | ₹0.92 lakh, up 2.3x YoY and 1.2x QoQ |
| Gurgaon Estate 360 collections (Q1) | ₹22.5 cr; ITD collections ₹556 cr, collection efficiency 87% |
| Antara management fee from Estate 360 | ₹3 cr accrued in Q1; ₹47.69 cr ITD |
| E361 Gurgaon: units sold in Q1 | 27 units; 34 units in July; ~194–197 units sold ITD |
| E361 Gurgaon: collections ITD | ₹108.2 cr |
| Noida Phase I: offers of possession issued | 340 residents in June 2026; demand raised ~₹169 cr |
| Noida Phase I: collections | ~₹30 cr collected in June; ~75% of total dues collected as of call date |
| Noida Phase I: average sale price range | ₹7,000–₹10,000 per sq ft historically; current rates ₹16,000–₹18,000+ |
| Care Home and Services revenue | ₹12.03 cr, up 1.5x YoY and 1.1x QoQ |
| Care Homes revenue standalone | 1.3x QoQ |
| Occupied bed days (OBDs) | +23% QoQ |
| Care Home occupancy: Bannerghatta, Bangalore | 41%, up from 37% in Q4 FY26 |
| Care Home occupancy: Gurugram | 41%, up from 33% in Q4 FY26 |
| Care Home occupancy: Whitefield, Bangalore | 18%, up from 8% in Q4 FY26 |
| Care Home occupancy: OMR Chennai | 12%, up from 3% in Q4 FY26 |
| Care Homes: patients served in Q1 | ~2,700; ~53,000 since inception |
| Care Homes: highest ARPOB achieved | ₹7,000+ in June 2026 across 4 Care Homes |
| Blended ARPOB target at stabilized occupancy | ~₹7,500 (management guidance) |
| Voice of customer score | 84% in Q1 FY27, stable in July |
| AGEasy net revenue | ₹19 cr, +1.3x YoY; lower than ₹23 cr in Q4 FY26 |
| AGEasy annual revenue run rate (ARR) | ~₹120 cr trending; July monthly run rate ~₹10 cr |
| AGEasy marketplaces revenue | ₹6 cr with ROAS of 3.8 |
| AGEasy D2C exit ROAS | 2.6 |
| AGEasy offline channel revenue | ₹5 cr, highest ever, +18% QoQ |
| AGEasy overall ROAS (exit Q1) | 2.0, up from 1.8 in Q4, +10% |
| AGEasy SAT index | 82% |
| AGEasy products live | 86 out of 112 launched |
| AGEasy diaper pack sales per day | 1,500, 6x growth in Amazon market share over 60 days |
| AGEasy patents | 4 granted, 3 filed |
| AGEasy lives touched | ~9 lakh; ~88,000 repeat customers; NPS ~60 |
| AGEasy repeat rate | ~10–12% |
| AGEasy online gross margins | 45% in Q1 vs 46% prior |
| AGEasy conversion rates | Improved from 2 to 3.5 |
| AGEasy CM2: marketplaces (July) | -17%, improved from historical -70% to -80% |
| AACS consolidated revenue | ₹30 cr (Q1 FY27) vs ₹21 cr (Q1 FY26) and ₹32 cr (Q4 FY26) |
| AACS consolidated EBITDA loss | ₹19 cr (Q1 FY27) vs ₹14 cr (Q1 FY26) and ₹18.5 cr (Q4 FY26) |
| Antara Integrated Wellness Clinic net revenue | ₹15.75 lakh; expected negative contribution margin in Q1 only |
| Wellness Clinic customer SAT score | 96%; average revenue per client ₹4,000 |
| Wellness Clinic footfalls | 307 sessions in June, up from 199 sessions |
| Total bed capacity (Assisted Care) | 485 beds across 8 Care Homes |
| Capital requirement: peak | ~$25 million, now reduced to ~$20 million or under |
| Incremental capital required (next 2 years) | ~$20 million |
| Second tranche of pref issue received | ₹40 cr in July 2026 |
| Bangalore opportunity: potential sales value | ~₹900 cr, ~300 units in Devanahalli |
| Dehradun new opportunity: potential sales value | ₹850–900 cr, <150 units |
| Combined pipeline sales value (Bangalore + Dehradun) | ~₹1,800 cr |
| EBITDA loss ratio trajectory | Dropped from 95% to 63% (FY25 to FY26) |